A citation-based method for searching scientific literature

Federica Cherchi, Irene Bulli, Martina Venturini, Anna Maria Pugliese, Elisabetta Coppi. Int J Mol Sci 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Géraldine Leva, Christian Klein, Jérémie Benyounes, François Hallé, Frédéric Bihel, Nicolas Collongues, Jérôme De Seze, Ayikoe-Guy Mensah-Nyagan, Christine Patte-Mensah. Biochim Biophys Acta Mol Basis Dis 2017
21
50

Involvement of ROS in BBB dysfunction.
Pamela B L Pun, Jia Lu, Shabbir Moochhala. Free Radic Res 2009
278
50


Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Avinash Parimisetty, Anne-Claire Dorsemans, Rana Awada, Palaniyandi Ravanan, Nicolas Diotel, Christian Lefebvre d'Hellencourt. J Neuroinflammation 2016
93
50

Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Joep Killestein, Nynke F Kalkers, Chris H Polman. J Neurol Sci 2005
58
50

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide.
Till Sprenger, Ludwig Kappos, Ernst-Wilhelm Radue, Laura Gaetano, Nicole Mueller-Lenke, Jens Wuerfel, Elizabeth M Poole, Steven Cavalier. Mult Scler 2020
16
50

Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis.
Xiaohong Chen, Lili Ma, Ying Jiang, Shaoqiong Chen, Cansheng Zhu, Mei Liu, Xiaomeng Ma, Dongliang Zhu, Yingying Liu, Fuhua Peng,[...]. Eur J Pharmacol 2012
16
50

Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
Kathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, Alexandra Balshi, Dermot Maher, Adam Kaplin, Bardia Nourbakhsh. Mult Scler 2021
4
50

Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis.
John Greenwood, Claire E Walters, Gareth Pryce, Naheed Kanuga, Evelyne Beraud, David Baker, Peter Adamson. FASEB J 2003
189
50

Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Xiaohong Chen, Rongbiao Pi, Mei Liu, Xiaomeng Ma, Ying Jiang, Yingying Liu, Xuexuan Mao, Xueqiang Hu. J Neuroimmunol 2010
17
50

Idebenone does not inhibit disability progression in primary progressive MS.
Peter Kosa, Tianxia Wu, Jonathan Phillips, Mika Leinonen, Ruturaj Masvekar, Mika Komori, Alison Wichman, Mary Sandford, Bibiana Bielekova. Mult Scler Relat Disord 2020
9
50

Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Meisam Sanoobar, Parvin Dehghan, Mohammad Khalili, Amirreza Azimi, Fatemeh Seifar. Nutr Neurosci 2016
50
50

Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis.
Andrea Rottlaender, Hannah Villwock, Klaus Addicks, Stefanie Kuerten. Immunology 2011
36
50

Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial.
M Rovaris, G Comi, M A Rocca, P Valsasina, D Ladkani, E Pieri, S Weiss, G Shifroni, J S Wolinsky, M Filippi. Mult Scler 2007
44
50


Correlation between EDSS scores and cervical spinal cord atrophy at 3T MRI in multiple sclerosis: A systematic review and meta-analysis.
Xiaodong Song, Dawei Li, Zhandong Qiu, Shengyao Su, Yan Wu, Jingsi Wang, Zheng Liu, Huiqing Dong. Mult Scler Relat Disord 2020
14
50


Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
Roberta Magliozzi, Owain Howell, Abhilash Vora, Barbara Serafini, Richard Nicholas, Maria Puopolo, Richard Reynolds, Francesca Aloisi. Brain 2007
884
50

Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation.
Makoto Sugawa, Yoko Sakurai, Yasuko Ishikawa-Ieda, Hiroshi Suzuki, Hiroaki Asou. Neurosci Res 2002
147
50

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Assunta Dal-Bianco, Günther Grabner, Claudia Kronnerwetter, Michael Weber, Romana Höftberger, Thomas Berger, Eduard Auff, Fritz Leutmezer, Siegfried Trattnig, Hans Lassmann,[...]. Acta Neuropathol 2017
175
50

Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Nicola De Stefano, Giancarlo Comi, Ludwig Kappos, Mark S Freedman, Chris H Polman, Bernard M J Uitdehaag, Brian Hennessy, Florence Casset-Semanaz, Lorenz Lehr, Bettina Stubinski,[...]. J Neurol Neurosurg Psychiatry 2014
17
50

Sex differences in multiple sclerosis.
Elizabeth Crabtree-Hartman. Continuum (Minneap Minn) 2010
4
50

Natural history of multiple sclerosis: a unifying concept.
Christian Confavreux, Sandra Vukusic. Brain 2006
551
50

Paroxysmal ataxia and dysarthria in multiple sclerosis.
R Iorio, F Capone, D Plantone, A P Batocchi. J Clin Neurosci 2014
14
50

Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter.
Ragnhildur Káradóttir, Nicola B Hamilton, Yamina Bakiri, David Attwell. Nat Neurosci 2008
243
50

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
Nelly Siller, Jens Kuhle, Muthuraman Muthuraman, Christian Barro, Timo Uphaus, Sergiu Groppa, Ludwig Kappos, Frauke Zipp, Stefan Bittner. Mult Scler 2019
112
50

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Helmut Butzkueven, Tim Spelman, Dana Horakova, Stella Hughes, Claudio Solaro, Guillermo Izquierdo, Eva Kubala Havrdová, Francois Grand'Maison, Alexandre Prat, Marc Girard,[...]. Eur J Neurol 2022
8
50

Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Dongxu Zhai, Frankie H F Lee, Cheryl D'Souza, Ping Su, Shouping Zhang, Zhengping Jia, Li Zhang, Albert H C Wong, Fang Liu. Ann Clin Transl Neurol 2015
16
50

Progressive multiple sclerosis: pathology and pathogenesis.
Hans Lassmann, Jack van Horssen, Don Mahad. Nat Rev Neurol 2012
562
50

Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis.
Nicola De Stefano, Diego G Silva, Michael H Barnett. CNS Drugs 2017
42
50


A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Emmanuelle Waubant, Amir-Hadi Maghzi, Nisha Revirajan, Rebecca Spain, Laura Julian, Ellen M Mowry, Jacqueline Marcus, Shuang Liu, Chengshi Jin, Ari Green,[...]. Ann Clin Transl Neurol 2014
28
50

Cross-species comparisons of the pharmacokinetics of ibudilast.
L M Sanftner, J A Gibbons, M I Gross, B M Suzuki, F C A Gaeta, K W Johnson. Xenobiotica 2009
16
50



Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity.
Lucas Schirmer, Wiebke Möbius, Chao Zhao, Andrés Cruz-Herranz, Lucile Ben Haim, Christian Cordano, Lawrence R Shiow, Kevin W Kelley, Boguslawa Sadowski, Garrett Timmons,[...]. Elife 2018
44
50


Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Laura Gaetano, Dieter A Häring, Ernst-Wilhelm Radue, Nicole Mueller-Lenke, Avinash Thakur, Davorka Tomic, Ludwig Kappos, Till Sprenger. Neurology 2018
36
50

Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis.
Jennetta W Hammond, Matthew J Bellizzi, Caroline Ware, Wen Q Qiu, Priyanka Saminathan, Herman Li, Shaopeiwen Luo, Stefanie A Ma, Yuanhao Li, Harris A Gelbard. Brain Behav Immun 2020
34
50

Orelabrutinib: First Approval.
Sohita Dhillon. Drugs 2021
16
50

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.
Elizabeth A Mills, Magdalena A Ogrodnik, Andrew Plave, Yang Mao-Draayer. Front Neurol 2018
95
50

Disruption of central nervous system barriers in multiple sclerosis.
Jorge Ivan Alvarez, Romain Cayrol, Alexandre Prat. Biochim Biophys Acta 2011
211
50


The clinical pharmacokinetics of cladribine.
J Liliemark. Clin Pharmacokinet 1997
109
50

Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis.
Martin Kerschensteiner, Florence M Bareyre, Bigna S Buddeberg, Doron Merkler, Christine Stadelmann, Wolfgang Brück, Thomas Misgeld, Martin E Schwab. J Exp Med 2004
106
50


Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
Ranjan Dutta, Ansi Chang, Mary K Doud, Grahame J Kidd, Michael V Ribaudo, Elizabeth A Young, Robert J Fox, Susan M Staugaitis, Bruce D Trapp. Ann Neurol 2011
210
50

Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.
Ileana Micu, Jason R Plemel, Andrew V Caprariello, Klaus-Armin Nave, Peter K Stys. Nat Rev Neurosci 2018
65
50

Therapeutic potential of lovastatin in multiple sclerosis.
Armando Sena, Rui Pedrosa, M Graça Morais. J Neurol 2003
68
50

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Douglas L Arnold, Ralf Gold, Ludwig Kappos, Amit Bar-Or, Gavin Giovannoni, Krzysztof Selmaj, Minhua Yang, Ray Zhang, Monica Stephan, Sarah I Sheikh,[...]. J Neurol 2014
58
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.